These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 921400)

  • 1. Influence of MAO inhibitors on uptake and release of norepinephrine in rat brain in vitro.
    Ziance RJ; Moxley K; Mullis M; Gray W
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):30-8. PubMed ID: 921400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phenylethanolamine N-methyltransferase inhibitors on uptake and release of norepinephrine and dopamine from rat brain.
    Liang NY; Hower JA; Borchardt RT
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):467-70. PubMed ID: 4059661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of fenfluramine and amphetamine on uptake release and catabolism of norepinephrine in rat brain.
    Ziance RJ; Rutledge CO
    J Pharmacol Exp Ther; 1972 Jan; 180(1):118-26. PubMed ID: 5010409
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of propranolol on rat brain norepinephrine in vitro.
    Ziance RJ
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):361-4. PubMed ID: 981791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of monoamine oxidase and catechol O-methyltransferase inhibitors on the accumulation and metabolism of [l-3H] norepinephrine by the adventitia and media of rabbit aorta.
    Levin JA; Wilson SE
    J Pharmacol Exp Ther; 1977 Dec; 203(3):598-609. PubMed ID: 925961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.
    Blier P; De Montigny C; Azzaro AJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):987-94. PubMed ID: 2423685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Types A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats.
    Westwood NN; Bryan-Lluka LJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):815-21. PubMed ID: 8246156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
    Yáñez M; Fraiz N; Cano E; Orallo F
    Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of amphetamine induced release of norepinephrine and serotonin from rat brain in vitro.
    Ziance RJ
    Res Commun Chem Pathol Pharmacol; 1977 Dec; 18(4):627-44. PubMed ID: 928960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of dopamine and norepinephrine metabolism in the rat brain by monoamine oxidase inhibitors.
    Buu NT; Angers M; Duhaime J; Kuchel O
    J Neural Transm; 1987; 70(1-2):39-50. PubMed ID: 3668521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent turnover of norepinephrine in the intact rat brain estimated from its rate of appearance in the cerebroventricular compartment.
    Levitt M; Kowalik S; Barkai AI
    J Neurosci Res; 1983; 10(1):93-9. PubMed ID: 6887283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
    Heikkila RE; Orlansky H; Mytilineou C; Cohen G
    J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the pharmacological and biochemical properties of substrate-selective monoamine oxidase inhibitors.
    Christmas AJ; Coulson CJ; Maxwell DR; Riddell D
    Br J Pharmacol; 1972 Jul; 45(3):490-503. PubMed ID: 5072232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SYMPATHOMIMETIC ACTIONS OF MONOAMINE OXIDASE INHIBITORS IN THE ISOLATING NICITATING MEMBRANE OF THE CAT.
    TSAI TH; FLEMING WW
    Biochem Pharmacol; 1965 Mar; 14():369-71. PubMed ID: 14314337
    [No Abstract]   [Full Text] [Related]  

  • 15. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
    Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
    Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 17. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
    MAXWELL DR; GRAY WR; TAYLOR EM
    Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.